RICHTER'S SYNDROME
Clinical trials for RICHTER'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new RICHTER'S SYNDROME trials appear
Sign up with your email to follow new studies for RICHTER'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody combo shows promise for stubborn leukemia
Disease control OngoingThis study tests an experimental antibody called epcoritamab, given alone or with other drugs, in people with chronic lymphocytic leukemia (CLL) or Richter's syndrome that has come back or not responded to treatment. About 195 adults will receive the drug under the skin or by mou…
Matched conditions: RICHTER'S SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
New pill shows promise for controlling blood cancer
Disease control OngoingThis study tests a new drug called acalabrutinib for people with chronic lymphocytic leukemia (CLL) or related blood cancers. The goal is to see if the drug is safe and can shrink or control the cancer. Participants take the drug by mouth, and the study tracks side effects and ho…
Matched conditions: RICHTER'S SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated May 11, 2026 20:38 UTC